These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 33901795)

  • 1. Tuning NO release of organelle-targeted furoxan derivatives and their cytotoxicity against lung cancer cells.
    Sodano F; Gazzano E; Rolando B; Marini E; Lazzarato L; Fruttero R; Riganti C; Gasco A
    Bioorg Chem; 2021 Jun; 111():104911. PubMed ID: 33901795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and anti-tumor evaluation of novel steroidal glycoconjugate with furoxan derivatives.
    Li H; Wang K; Wan Q; Chen Y
    Steroids; 2019 Jan; 141():81-95. PubMed ID: 30521816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and biological evaluation of hybrid bioisoster derivatives of N-acylhydrazone and furoxan groups with potential and selective anti-Trypanosoma cruzi activity.
    Massarico Serafim RA; Gonçalves JE; de Souza FP; de Melo Loureiro AP; Storpirtis S; Krogh R; Andricopulo AD; Dias LC; Ferreira EI
    Eur J Med Chem; 2014 Jul; 82():418-25. PubMed ID: 24929292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Furoxans and tocopherol analogs-furoxan hybrids as anticancer agents.
    Pérez F; Varela M; Canclini L; Acosta S; Martínez-López W; López GV; Hernández P
    Anticancer Drugs; 2019 Apr; 30(4):330-338. PubMed ID: 30489292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor platinum(II) complexes containing platinum-based moieties of present platinum drugs and furoxan groups as nitric oxide donors: synthesis, DNA interaction, and cytotoxicity.
    Zhao J; Gou S; Sun Y; Fang L; Wang Z
    Inorg Chem; 2012 Oct; 51(19):10317-24. PubMed ID: 22957695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel diosgenin derivatives containing 1,3,4-oxadiazole/thiadiazole moieties as potential antitumor agents: Design, synthesis and cytotoxic evaluation.
    Zhang J; Wang X; Yang J; Guo L; Wang X; Song B; Dong W; Wang W
    Eur J Med Chem; 2020 Jan; 186():111897. PubMed ID: 31761382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Structural Hybrids on the Base of Benzofuroxans and Furoxans. Mini-Review.
    Chugunova EA; Burilov AR
    Curr Top Med Chem; 2017; 17(9):986-1005. PubMed ID: 27697059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of furoxan-based nitric oxide-releasing derivatives of tetrahydroisoquinoline as anticancer and multidrug resistance reversal agents.
    Zou ZH; Lan XB; Qian H; Huang WL; Li YM
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5934-8. PubMed ID: 21843940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide-donating derivatives of hederacolchiside A
    Fang Y; Wang R; He M; Huang H; Wang Q; Yang Z; Li Y; Yang S; Jin Y
    Bioorg Med Chem Lett; 2017 Jan; 27(1):98-101. PubMed ID: 27866816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of furoxan-based nitric oxide-releasing derivatives of glycyrrhetinic acid as anti-hepatocellular carcinoma agents.
    Lai Y; Shen L; Zhang Z; Liu W; Zhang Y; Ji H; Tian J
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6416-20. PubMed ID: 20932754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel NO-releasing plumbagin derivatives: Design, synthesis and evaluation of antiproliferative activity.
    Bao N; Ou J; Xu M; Guan F; Shi W; Sun J; Chen L
    Eur J Med Chem; 2017 Sep; 137():88-95. PubMed ID: 28558333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New oxadiazoles with selective-COX-2 and EGFR dual inhibitory activity: Design, synthesis, cytotoxicity evaluation and in silico studies.
    El-Sayed NA; Nour MS; Salem MA; Arafa RK
    Eur J Med Chem; 2019 Dec; 183():111693. PubMed ID: 31539778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of nitric oxide-releasing derivatives of farnesylthiosalicylic acid as anti-tumor agents.
    Ling Y; Ye X; Ji H; Zhang Y; Lai Y; Peng S; Tian J
    Bioorg Med Chem; 2010 May; 18(10):3448-56. PubMed ID: 20435479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New furoxan derivatives for the treatment of ocular hypertension.
    Blangetti M; Rolando B; Chegaev K; Guglielmo S; Lazzarato L; Durante M; Masini E; Almirante N; Bastia E; Impagnatiello F; Fruttero R; Gasco A
    Bioorg Med Chem Lett; 2017 Feb; 27(3):479-483. PubMed ID: 28027869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity of furoxans: quantitative structure-activity relationships study.
    Boiani M; Cerecetto H; González M
    Farmaco; 2004 May; 59(5):405-12. PubMed ID: 15120320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and Biological Evaluation of New 1,3,4-Oxadiazoles as Potential Anticancer Agents and Enzyme Inhibitors.
    Yurttaş L; Çavuşoğlu BK; Çiftçi GA; Temel HE
    Anticancer Agents Med Chem; 2018; 18(6):914-921. PubMed ID: 29577865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and in vitro NO-releasing activities of ocotillol-type furoxans.
    Bi Y; Yang J; Ma C; Liu ZY; Zhang TT; Zhang XC; Lu J; Meng QG
    Pharmazie; 2015 Apr; 70(4):213-8. PubMed ID: 26012249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new class of furoxan derivatives as NO donors: mechanism of action and biological activity.
    Ferioli R; Folco GC; Ferretti C; Gasco AM; Medana C; Fruttero R; Civelli M; Gasco A
    Br J Pharmacol; 1995 Feb; 114(4):816-20. PubMed ID: 7773542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo phase II-enzymes inducers, as potential chemopreventive agents, based on the chalcone and furoxan skeletons.
    Cabrera M; Mastandrea I; Otero G; Cerecetto H; González M
    Bioorg Med Chem; 2016 Apr; 24(8):1665-74. PubMed ID: 26970663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide-donating and reactive oxygen species-responsive prochelators based on 8-hydroxyquinoline as anticancer agents.
    Zhang Y; Yang J; Meng T; Qin Y; Li T; Fu J; Yin J
    Eur J Med Chem; 2021 Feb; 212():113153. PubMed ID: 33453603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.